| Autor: |
Taieb A; Endocrinology and Diabetes Department, University Hospital Farhat Hached Sousse, Tunisia., Maha KN; Endocrinology and Diabetes Department, University Hospital Farhat Hached Sousse, Tunisia., El Abed YH; Endocrinology and Diabetes Department, University Hospital Farhat Hached Sousse, Tunisia., Beizig AM; Endocrinology and Diabetes Department, University Hospital Farhat Hached Sousse, Tunisia., Chadli MC; Endocrinology and Diabetes Department, University Hospital Farhat Hached Sousse, Tunisia., Ach K; Endocrinology and Diabetes Department, University Hospital Farhat Hached Sousse, Tunisia. |
| Jazyk: |
angličtina |
| Zdroj: |
The Pan African medical journal [Pan Afr Med J] 2017 Aug 14; Vol. 27, pp. 278. Date of Electronic Publication: 2017 Aug 14 (Print Publication: 2017). |
| DOI: |
10.11604/pamj.2017.27.278.11361 |
| Abstrakt: |
Macroprolactinemia is a polymeric form of prolactin-release, causing mildly symptomatic clinical pictures. The former can be isolated or associated with other causes of hyperprolactinemia. The association with an empty sella syndrome is rare. We report a case of a female patient discovered with this association. It's about a female patient 47 years old, followed up since the age of 31 years for bilateral galactorrhea and a spaniomenorrhea. There has been no associated drug intake. Her exploration has showed a serum prolactin level of 635 mIU/L. Thyroid test results were normal T4 = 10,2ng/L and TSH = 1.76 mIU/L. A brain scan has showed an empty sella turcica. Despite the unchanged levels of prolactinemia, the evolution under dopaminergic 5 mg /D has been marked by the occurrence of a pregnancy with persistent moderate hyperprolactinemia in the postpartum. Chromatography has showed a predominance of the macroprolactin form with: Prolactin monomer at 4.8%, Big Prolactin at 5% and Big Big Prolactin at 83%, thus stopping bromocriptine. Our observation suggests that macroprolactinemia can be associated with conventional etiologies of moderate hyperprolactinemia as the empty sella syndrome. Its detection would prevent the use of dopaminergic therapy which seems not useful. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
